This inventor holds 6 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Ben-Gurion University of the Negev Research and Development Authority, Vecta, Ltd.. Active years: 2010-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Negev, IL (2010)
- Omer, IL (2014 - 2021)
Company Filing History:

Years Active: 2010-2021
Title: Ayelet David: Innovator in Cell-Penetrating Peptide Technology
Introduction
Ayelet David is a prominent inventor based in Omer, Israel, known for her significant contributions to the field of biotechnology. With a total of six patents to her name, she has made remarkable advancements in the development of caged cell-penetrating peptide-polymer conjugates. These innovations have the potential to revolutionize diagnostic and therapeutic applications in medicine.
Latest Patents
Ayelet David's latest patents focus on caged cell-penetrating peptide (cCPP) conjugates designed for intracellular delivery of various cargoes. These cargoes include nanoparticle pharmaceutical carriers such as liposomes, micelles, microparticles, and polymer-conjugates. The conjugates are engineered to include either a detectable agent or a therapeutic agent, providing a novel strategy for site-specific delivery to targeted tissues. The versatile applications of these conjugates in diagnostics and imaging are also highlighted in her work.
Career Highlights
Throughout her career, Ayelet has worked with esteemed institutions, including the Ben-Gurion University of the Negev Research and Development Authority and Vecta, Ltd. Her work has significantly impacted the field of biotechnology, particularly in the development of innovative delivery systems for therapeutic agents.
Collaborations
Ayelet has collaborated with notable colleagues, including Yosi Shamay and Gonen Ashkenasy, contributing to her research and development efforts in the field.
Conclusion
Ayelet David's innovative work in caged cell-penetrating peptide technology showcases her dedication to advancing medical science. Her contributions have the potential to enhance the effectiveness of therapeutic applications and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile